阿里巴巴(9988.HK)翻紅 今日盤後放榜 二季度收入料增長近30%
格隆匯8月20日丨阿里巴巴(9988.HK)臨近尾盤翻紅,現報255.6港元,微漲0.08%,總市值54856億港元。阿里巴巴將於今日收盤後放榜並舉行業績會,投資者除關注業務復甦情況外,美國政府施壓中資科技股、中概股審計收緊、螞蟻集團上市、同業競爭等亦成為市場重點關注問題。綜合彭博數據,市場預測阿里巴巴今年二季度收入同比增長29%至1481億元,Non-GAAP淨利潤則同比升17%至362億元。招銀國際認為,阿里巴巴上季度在國內市場的復甦較預期更快,在直播帶貨、618促銷、政府消費補貼等支持下,阿里市佔率也有望進一步提升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.